Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation
- PMID: 27479544
- DOI: 10.1111/tid.12581
Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation
Abstract
Background: Infectious complications are a significant cause of hematopoietic stem cell transplantation (HSCT) failure, especially allogeneic HSCT (allo-HSCT) because of delayed immune reconstitution and graft-versus-host disease (GVHD) occurrence. Identifying the factors responsible for bacterial infections (BI) in patients undergoing HSCT will provide much more effective empirical antimicrobial treatment in this group of patients.
Objective: The aim of this study was to evaluate the epidemiology and profile of BI in patients after HSCT in 5 centers of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation in 2012-2013.
Patients and methods: In 308 HSCT recipients, we retrospectively analyzed 273 episodes of BI in 113 (36.7%) children aged 0.02-22 years (median age: 7 years), 92 after allo-HSCT and 22 after autologous HSCT (auto-HSCT). We assessed incidence of BI in different HSCT types by calculating the Index of Bacterial Infection (IBI) as a ratio of patients with at least 1 BI to all patients who underwent this type of HSCT in the analyzed period. We assessed the profile of BI with particular emphasis on multidrug-resistant organisms, and impact of underlying disease and of graft-versus-host disease on BI episodes.
Results: In the studied group, 273 episodes of BI were diagnosed, including 237 episodes after allo-HSCT and 36 after auto-HSCT. Among allo-HSCT recipients diagnosed with at least 1 BI, the IBI was 0.4 (matched sibling donor-HSCT 0.3; matched donor-HSCT 0.4; mismatched unrelated donor [MMUD]-HSCT 0.8; P = 0.027) and after auto-HSCT 0.3 per 1 transplanted patient. In patient after allo-HSCT because of myelo- or lymphoproliferative diseases and bone marrow failures, the major cause of infections was Enterobacteriaceae, while gram-positive bacteria predominated in the group with primary immunodeficiencies. In all patients after auto-HSCT, the dominant pathogen of BI were Enterobacteriaceae (P = 0.011). Time from each type of HSCT to infection caused by different pathogens did not differ significantly.
Conclusions: The risk of BI does not depend on the underlying disease, but only on HSCT donor type and is the highest after MMUD-HSCT procedure. The profile of BI depends on the underlying disease and HSCT donor type, but does not depend on the occurrence of acute GVHD. Gram-negative bacteria predominated in patients with myelo- and lymphoproliferative diseases, while in patients with primary immunodeficiencies gram-positive strains were predominant.
Keywords: bacterial infection; children; epidemiology; hematopoietic stem cell transplantation; multidrug resistance.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Multidrug-resistant bacterial infections in children undergoing haematopoietic stem cell transplantation over a 6-year period: analysis of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.J Appl Microbiol. 2020 Jan;128(1):292-300. doi: 10.1111/jam.14452. Epub 2019 Oct 3. J Appl Microbiol. 2020. PMID: 31529556
-
[A comparative study of unrelated donor and matched-sibling donor allogeneic hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia].Zhonghua Nei Ke Za Zhi. 2016 Dec 1;55(12):927-931. doi: 10.3760/cma.j.issn.0578-1426.2016.12.004. Zhonghua Nei Ke Za Zhi. 2016. PMID: 27916046 Chinese.
-
Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.J Microbiol Immunol Infect. 2018 Feb;51(1):123-131. doi: 10.1016/j.jmii.2016.02.003. Epub 2016 Mar 17. J Microbiol Immunol Infect. 2018. PMID: 27103500
-
Development and current use of in hematopoietic stem cell transplantation in children and adolescents in Poland: Report of the Polish pediatric study group for hematopoietic stem cell transplantation of the Polish society for pediatric oncology and hematology.Transfus Apher Sci. 2018 Jun;57(3):316-322. doi: 10.1016/j.transci.2018.05.012. Epub 2018 May 16. Transfus Apher Sci. 2018. PMID: 29880247 Review.
-
Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.Transpl Infect Dis. 2017 Apr;19(2). doi: 10.1111/tid.12669. Epub 2017 Mar 31. Transpl Infect Dis. 2017. PMID: 28128496 Review.
Cited by
-
Comment on: Bacteremia in pediatric patients with hematopoietic stem transplantation.Hematol Transfus Cell Ther. 2020 Jan-Mar;42(1):1-4. doi: 10.1016/j.htct.2020.01.001. Epub 2020 Jan 29. Hematol Transfus Cell Ther. 2020. PMID: 32037188 Free PMC article. No abstract available.
-
Emergency Combination of Four Drugs for Bloodstream Infection Caused by Carbapenem-Resistant Enterobacteriaceae in Severe Agranulocytosis Patients with Hematologic Malignancies after Hematopoietic Stem Cell Transplantation.Emerg Med Int. 2020 Aug 4;2020:9358426. doi: 10.1155/2020/9358426. eCollection 2020. Emerg Med Int. 2020. PMID: 32832159 Free PMC article.
-
The Resistome of ESKAPEE Pathogens in Untreated and Treated Wastewater: A Polish Case Study.Biomolecules. 2022 Aug 21;12(8):1160. doi: 10.3390/biom12081160. Biomolecules. 2022. PMID: 36009054 Free PMC article.
-
Early pulmonary complications related to cancer treatment in children.Pediatr Radiol. 2022 Sep;52(10):2017-2028. doi: 10.1007/s00247-022-05403-w. Epub 2022 Jul 2. Pediatr Radiol. 2022. PMID: 35778572 Review.
-
Bacteremia in pediatric patients with hematopoietic stem cell transplantation.Hematol Transfus Cell Ther. 2020 Jan-Mar;42(1):5-11. doi: 10.1016/j.htct.2019.05.006. Epub 2019 Aug 11. Hematol Transfus Cell Ther. 2020. PMID: 31519531 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical